Hims & Hers stockholders approve all proposals at 2022 annual meeting

Hims & Hers Health, Inc.

Elected ten directors, including CEO Andrew Dudum, with over 1.5B votes each; broker non-votes ~41.4M.
Ratified KPMG as independent auditor for FY2022: 1.57B for, 656,788 against, 617,606 abstentions.
Advisory say-on-pay approved: 1.53B for, 3.2M against, 725,386 abstentions.
Stockholders chose one-year frequency for future advisory votes on executive compensation.
Board determined to hold annual say-on-pay votes until next frequency vote expected at 2028 meeting.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.